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Abstract
The purpose of the study was to investigate a new drug of entomological origin isolated from the pupae of Lepidoptera.  Experiments were 
performed on young mice 18-20 g, which were divided into 3 groups: a control group and two groups that received a suspension of the drug 
in the amount of 0.5 ml of saline at doses of 1000 and 100 micrograms per mouse, respectively.  There was a strong stimulation of nonspecific 
resistance of the organism as a result of the use of Imupurin as demonstrated by increased phagocytosis capacity of peritoneal neutrophils and 
macrophages (marked increase in phagocytant neutrophils and macrophages, namely reducing the nonphagocytant).  The results showed that in 
doses of 100 and 1000 micrograms Imupirin increased the number of phagocytant neutrophils by 3.16 and 3.49 times and increased the number 
of phagocytant macrophages by 3.66 and 3.55 times, respectively, compared to the control.  The observed effects of the entomological drug did 
not depend on the dose, which indicates that the effects on phagocytosis depend mainly on the composition of Imupurin (proteins, lipids) and 
to a lesser extent on the quantity.
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Фагоцитоз и его изменения под влиянием имупурина
Цель исследования – изучение действия  нового препарата энтомологического происхождения, выделенный из куколок Lepidoptera. 
Опыты были произведены на молодых мышках 18-20 г, которые были подразделены на 3 группы с использованием суспензии препарата в 
объеме 0,5 мл физиологического раствора в дозах 1000 и 100 микрограмм на мышку.  Наблюдается сильная стимуляция неспецифической 
резистентности организма вследствие употребления имупурина, в результате повышения способности к фагоцитозу нейтрофилов 
и макрофагов.  Результаты опытов показали, что имупурин в дозах 100 и 1000 микрограмм увеличил количество фагоцитирующих 
нейтрофилов в 3,16 и 3,49 раз и количество фагоцитирующих макрофагов в 3,66 и 3,55 раз, соответственно по сравнению с контролем. 
Именно в этих пропорциях имупурин уменьшил количество нефагоцитирующих нейтрофилов и макрофагов, не участвующих в 
фагоцитозе.  Для определения фагоцитарного индекса была выделена тенденция к повышению способности фагоцита поглощать 
большее количество стафилококков.  Анализ фагоцитарного индекса позволил констатировать, что последний, при использовании 
имупурина в соответствующих дозах, вырос по отношению к контролю в 3 раза.  Выявленные эффекты энтомологического препарата 
не зависит от дозы, что указывает на то, что стимулирующее действие на фагоцитоз зависит, в основном, от состава имупурина 
(протеины, липиды) и, в меньшей степени, от количества.
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Introduction
The research done so far has shown that insects’ tissues 
contain lipoprotein complex structures with immune modu-
latory effect, i.e. consumed products in various ways conside-
rably increase the human immune system against unfavorable 
environmental actions and infections of various pathogenic 
agents, including viral infections.  Thus, we can ascertain a 
possible method to stimulate the immune system, which surely 
would increase human life expectancy [2, 3].
The recent increase in researchers’ interest in insects is 
partly due to their immune system.  Although their immune 
system is different from that of humans, studying them might 
help us overcome many illnesses.  For instance, insects are able 
to destroy microbe cells with the help of some receptor mole-
cules in their body and to synthesize peptide as a protection 
system against microbes [1, 4].
Material and Methods
To identify the action of the entomologic drug Imupurin 
upon the process of phagocytosis, the recommendations ap-
proved by State Pharmacological Committee of the Russian 
Ministry of Health (Moscow 2005) have been followed [5]. 
To identify the action of phagocytosis in vivo, 30 mice were 
used. The control number contained 10 mice which were 
given 0.5 ml of intraperitoneal physiological solution.  The 
following two experimental groups (10 mice each) were given 
drug suspension in an amount of 0.5 ml physiological solution 
according to the methodical recommendations (1000 and 100 
mkg for each mouse) [5].
Activity of phagocytosis of peritoneal neutrophils and 
macrophage were observed.  The mice were given 3-4 
ml of 2-3% of intraperitoneal bullion and after 24 hours 
they were sacrificed with clorophorm.  Subsequently, the 
intraperitoneal liquid was extracted according to the re-
commendations mentioned above by injecting the material 
with Staphylococcus aureus.
The results were determined microscopically. The number 
of peritoneal neutrophils and macrophages were counted 
from the sample. The index of phagocytosis and the percent 
of phagocytant cells of each group were counted.  We also 
determined the phagocytosis activity of neutrophils and 
macrophage by analyzing the phagocytary index (PI), i.e. the 
percent of phagocytant cells out of their total amount, and 
the phagocytary number (PN), i.e. the number of phagocyted 
bacteria by a neutrophils (obtained out of the media of pha-




The results of the experiments proved that Imupurin con-
tributes to the increased amount of phagocytant neutrophils, 
and respectively, the decrease of those non-phagocytant (tab. 
1). 
Thus, the drug of 100-1000 micrograms per mouse increa-
sed the number of phagocytant neutrophils from 3.16 to 3.43.
Respectively, Imupurin reduced the number of non pha-
gocytant neutrophils.  Concomitant, an essential increase was 
established in the number of phagocyted Staphilococcus (tab. 
1).  Thus, neutrophils phagocyted 226.6 ± 11.4 microbs in 
the control group, this number increased to 820.3 ± 16.8 and 
801.6 ± 27.3 Staphilococcus or 3.6 and  3.5 times at the doses 
100 mkg and 1000 mkg. 
Table 1
The action of Imupurin on the neutrophyls activity  














Control 10 24.6±1.4  75.4±4.43 226.6±11.4
1000 mkg/  
per animal 10 82.5±1.26* 17.5±4.0* 801.6±27.3*
100 mkg /  
per animal 10 77.7±0.87* 22.3±2.75 * 820.3±16.8*
* - veridical deviation,   p < 0,001.
For detailed phagocytosis analysis, the activity of neutro-
phils was determined  charactirized by the phagocytary index 
and the phagocytary number. 
The phagocytary number increased from 9.5 ± 0.85 in the 
control group to 10.6 ± 0.18 and 9.7± 0.36 in study groups with 
Imupurin in the doses  100 and 1000 mkg per animal (tab. 2). 
The analysis of respective parameters allowed us to find 
that the phagocytary indexes have increased from 24.6 ± 1.4 
(in the control group) to 74.7 ± 0.87 and 82.5 ± 1.27 in groups 
given Imupurin (p < 0.001). 
The increasing phagocytary index, though non-veridical, 
shows the phagocytary capacity of a neutrophil.  All this per-
mit us to conclude, that Imupurin increases the number and 
phagocytary activity of neutrophils (fig. 1).
Tabel 2
The action of imupurin in the doses of 1000 and 100 mkg/










Phagocytary index 24.6±1.4  82.5±1.27* 77.7±0.87*
Phagocytary number 9.5±0.85 9.7±0.36 10.6±0.18
* - Veridical deviation,   p < 0.001.
The obtained data suggest a hypothesis that Imupurin 
stimulant action on phagocytosis doesn’t depend on the ad-
ministrated doses therefore it is not a dose dependent action, 
but it depends on lipoproteic complexes from Imupurin com-
position, which are inductors of neutrophils activity. 
Fig. 1.  The action of Imupurin on the functional 
neutrophils activity  
Tabel 3
The effect of Imupurin on the activity of macrophages and 
the number of phagocyted Staphilococcus 
Groups and 

















10 81.0±1.49* 20.0±0.9* 828.2±22.1*
III group
100mcg //  
per animal
10 83.1±1.65* 16.9±1.65* 820.3±14.8*
* - Veridical deviation, p < 0.001.
Because phagocytes are one of the first defense barriers 
of the body against infection, the influence of Imupurin on 
the number and phagocytary activity of macrophages was 
studied (tab. 3).
The experimental study has demonstrated that Imu-
purin (100 and 1000 mkg per animal) increases the pha-
gocytant macrophages number (by 3.66 or 3.55 times) in 
comparison with the control group (tab. 3).  Concomitant, 
the same drug proportion reduced the number of non-pha-
gocytant macrophages (tab.3).  Simultaneously, Imupurin 
increases the number of phagocyted Staphylococcus aureus 
by macrophages. In this way, this parameter constituted 
820.3 ± 14.8 and 828.2 ± 22.1 comparative with the control 
group (217.1±10.5) (p < 0.001).
The phagocytary index is in correlation with the reported 
data, and its increase is similar with the number of phago-
cytant macrophages (tab. 4).  The phagocytary number noted 
an intensification of one macrophage’s activity to phagocyte 
more Staphylococcus (fig. 2). Accordingly, the contrary with 
a significant increase of phagocytant macrophages it is noted 
a light activity of the phagocytary number. 
The constant effects of entomologic drugs are not dose 
dependent. Probably, the stimulatory action on phagocytosis 
depends more on the composition of Imupurin (proteins, 
lipids) than their quantity. 
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Tabel 4 
The action of Imupurin in the doses of 1000 and 100 mkg/










Phagocytary index 22.7±1.13 81.0±1.49* 83.1±1.65*
Phagocytary number 9.73±0.64 10.24±0.29 9.90±0.26
* - veridical deviation,   p < 0.001.
Fig. 2.  The action of Imupurin on the functional 
macrophages activity
Conclusions
1. Imupurin is an entomologic drug with certain immu-
notrop properties.
2. Imupurin has a stimulant action on phagocytosis, a fact 
manifested through the increasing of the indexes characteristic 
for phagocytosis. 
3. Lipoproteic complexes from Imupurin composition 
may be considered responsible for the stimulatory action 
on phagocytary macrophages and neutrophils action and 
Staphylococcus infection eradication. 
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